Correlation Between Pfizer and Instituto Rosenbusch

Can any of the company-specific risk be diversified away by investing in both Pfizer and Instituto Rosenbusch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Instituto Rosenbusch into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Instituto Rosenbusch SA, you can compare the effects of market volatilities on Pfizer and Instituto Rosenbusch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Instituto Rosenbusch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Instituto Rosenbusch.

Diversification Opportunities for Pfizer and Instituto Rosenbusch

-0.35

Correlation Coefficient

Pfizer  Instituto Rosenbusch

Very good diversification

The 3 months correlation between Pfizer and Instituto is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Instituto Rosenbusch SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instituto Rosenbusch and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Instituto Rosenbusch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instituto Rosenbusch has no effect on the direction of Pfizer i.e., Pfizer and Instituto Rosenbusch go up and down completely randomly.

Pair Corralation between Pfizer and Instituto Rosenbusch

Assuming the 90 days trading horizon Pfizer Inc is expected to under-perform the Instituto Rosenbusch. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.86 times less risky than Instituto Rosenbusch. The stock trades about -0.3 of its potential returns per unit of risk. The Instituto Rosenbusch SA is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  9,800  in Instituto Rosenbusch SA on September 15, 2024 and sell it today you would earn a total of  1,675  from holding Instituto Rosenbusch SA or generate 17.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Instituto Rosenbusch SA

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Instituto Rosenbusch

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Instituto Rosenbusch SA are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Instituto Rosenbusch sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Instituto Rosenbusch

The main advantage of trading using opposite Pfizer and Instituto Rosenbusch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Instituto Rosenbusch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instituto Rosenbusch will offset losses from the drop in Instituto Rosenbusch's long position.

The idea behind Pfizer Inc and Instituto Rosenbusch SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.